Viewing nowHuruma Tablet (Talniflumate)
Talniflumate 370mg
Tablet · Prescription medication
Myungmoon Pharmaceutical Co., Ltd.

MFDS item code 199401949 · Notified 1994.09.29 · Insurance code 649803780
Treatment of arthritis (such as rheumatoid arthritis)
Rheumatoid arthritis and osteoarthritis are conditions that cause inflammation and pain in the joints. Rheumatoid arthritis is a chronic condition characterized by inflammation in the joints due to an abnormal immune response, while osteoarthritis is a degenerative condition in which the cartilage in the joints wears down, leading to pain and limited mobility. This medication is used to relieve symptoms of arthritis, reduce inflammation, and improve joint function.
Administer talniflumate orally at 370 mg per dose, 3 times daily. For severe cases, administer 740 mg per dose. Adjust the dose as needed according to age and symptoms.
This medication may pose a risk of gastrointestinal bleeding if taken by individuals who consume more than three alcoholic drinks daily, so it is essential to consult a doctor or pharmacist. This medication can cause problems with the heart and blood vessels, so those with cardiovascular disease or risk factors should use it cautiously and consult a medical professional immediately if symptoms occur. This medication can cause severe issues such as gastrointestinal bleeding or ulcers, so elderly individuals or those with a history of gastrointestinal disorders need to be particularly careful and seek treatment immediately if symptoms arise. Persons with peptic ulcers, allergies to this medication, severe liver, kidney, or heart conditions, and women who are pregnant or breastfeeding should not take this medication. Individuals with slightly reduced liver or kidney function, the elderly, or those taking diuretics should use this medication cautiously. If abnormal symptoms such as nausea, vomiting, diarrhea, abdominal pain, skin rash, difficulty breathing, or dizziness occur during treatment, consult a medical professional immediately. It is advisable not to take this medication with other nonsteroidal anti-inflammatory drugs, and interactions may occur with specific blood pressure medications, anticoagulants, lithium, methotrexate, etc., so it is critical to consult a medical professional. This medication should not be taken during pregnancy, especially in late pregnancy, as it may harm the fetus. If breastfeeding, it is recommended to either stop breastfeeding or discontinue the medication due to the lack of established safety. This medication should not be used in children under 12 years of age, and the elderly should use the minimum dosage cautiously and be vigilant for adverse reactions. This medication should be stored out of reach of children and not transferred to another container for safety.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. Additionally, it is best to keep it at normal room temperature, not too hot or too cold.
Pale yellow round film-coated tablet
30 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTalniflumate 370mg
Tablet · Prescription medication
Myungmoon Pharmaceutical Co., Ltd.

Talniflumate 370mg
Tablet · Prescription medication
Albozen Korea Co., Ltd.

Talniflumate 370mg
Tablet · Prescription medication
Dongsung Pharm Co., Ltd.

Talniflumate 370mg
Tablet · Prescription medication
Daewoo Pharmaceutical Co., Ltd.
Talniflumate 370mg
Tablet · Prescription medication
Samchundang Pharmaceutical Co., Ltd.

Talniflumate 370mg
Tablet · Prescription medication
Taegeuk Pharmaceutical Co., Ltd.

Talniflumate 370mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Talniflumate 370mg
Tablet · Prescription medication
Daehwa Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.